近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1.Wang J, Mao Y, Liu Y, Chen Z, Chen M, Lao X, Li S*. Hepatocellular Carcinoma in Children and Adolescents: Clinical Characteristics and Treatment. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. Apr 10 2017.（IF=2.8） 2.Mao Y, Xu S, Hu W, J. Huang, J. Wang, R. Zhang, S. Li*. Imaging features predict prognosis of patients with combined hepatocellular-cholangiocarcinoma. Clinical radiology. Feb 2017;72(2):129-135.（IF=2.1） 3.Chen JL, Lao XM, Lin XJ, Xu L, Cui BK, Wang J, Lin GH, Shuang ZY, Mao YZ, Huang X, Yun JP, Jin JT, Li SP*.Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection. Medicine 2016; 95: 5(1-10). (IF：2.13) 4.Lin G, Liu Y, Li S, Mao Y, Wang J, Shuang Z, Chen J, Li S*. Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma. Oncotarget 2016；DOI: 10.18632/oncotarget.7680.(IF：5.0) 5.Chen, JL, Lin XJ, Zhou Q, Shi M, Li SP*, Lao XM*. Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection. Chinese journal of cancer 2016; 35: 1, (28-41). (IF：2.81) 6.Xu L, Wang J, Kim Y, Shuang ZY, Zhang YJ, Lao XM, Li YQ, Chen MS, Pawlik T.M., Lau WY, Xia JC, Li SP*，Lau Wanyee. A randomized controlled trial on patients with or without adjuvant autologous cytokine-induced killer cells after curative resection for hepatocellular carcinoma. Oncoimmunology 2016；DOI/full/10.1080/2162402X.2015.1083671.(IF：7.64) 7.Zhang MY, Li SH, Huang GL, Lin GH, Shuang ZY, Lao XM, Xu L, Lin XJ, Wang HY* and Li SP*.Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis. BMC Cancer 2015 ;15:64 (1-8). (IF:3.3) 8.Shuang ZY, Wu WC, Xu J, Lin G, Liu YC, Lao XM, Zheng L, Li S* . Transforming growth factor-β1-induced epithelial-mesenchymal transition generates ALDH-positive cells with stem cell properties in cholangiocarcinoma. Cancer Lett 2014, 354:320-328.(IF:5.6) 9.Zhang PP, Wang XL, Zhao W, Qi B, Yang Q, Wan HY, Shuang ZY, Liu M, Li X, Li S*, Tang H. DNA Methylation-mediated Repression of miR-941 Enhances Lysine (K)-specific Demethylase 6B Expression in Hepatoma Cells. J Biol Chem 2014, 289: 24724-24735. (IF:4.5) 10.刘永成, 李书红, 双泽宇, 陈建霖, 李升平(通讯作者).术前外周血中性粒细胞/淋巴细胞比值对肝内胆管细胞癌术后预后的影响.中国普通外科杂志,2014,23(02):160-165. 11.Yan yan, Yue-Chen Luo, Hai-Ying Wan, Jun Wang, Pei-Pei Zhang, Min Liu, Xin Li, Shengping Li*, Hua Tang. MiR-10a is involved in metastatic process by regulating EphA4-mediated epithelial-mesenchymal transition and adhesion in hepatoma cells. Hepatology 2013, 57:667-677.(IF:11.0) 12.Liao Y, Wang B, Huang ZL, Shi M, Yu XJ, Zheng L, Li S*, Li L. Increased circulating Th17 cells after transarterial chemoembolization correlate with improved survival in stage III hepatocellular carcinoma: a prospective study. PLoS One 2013, 8:e60444 (1-9).(IF:3.2) 13.Lao XM, Luo G, Ye LT, Luo C, Shi M, Wang D, Guo R, Chen M, Li S*, Lin X, Yuan Y. Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma. Liver Int 2013, 33:595-604.(IF:4.8) 14.Pan K, Li YQ, Wang W, Xu L, Zhang YJ, Zheng HX, Zhao JJ, Qiu HJ, Weng DS, Li JJ, Wang QJ, Huang LX, He J, Chen SP, Ke ML, Wu PH, Chen MS, Li SP*, Xia JC, Zeng YX. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients. Ann Surg Oncol 2013, 20:4305-4311.(IF:3.9) 15.Xu S, Wu Y, Chen Q, Cao J, Hu K, Tang J, Sang Y, Lai F, Wang L, Zhang R, Li SP, Zeng YX, Yin Y, Kang T. hSSB1 regulates both the stability and the transcriptional activity of p53. Cell Res 2013, 23:423-35. (IF:12.4) 16.Shengping Li, Ji Qian, Yuan Yang, Wanting Zhao,et al. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet 2012, 8:e1002791(1-9). (IF:7.5) 17.Lin G, Wang J, Lao X, Wang J, Li L, Li S, Zhang J, Dong Y, Chang AE, Li Q, Li S *. Interleukin-6 Inhibits Regulatory T Cells and Improves the Proliferation and Cytotoxic Activity of Cytokine-induced Killer Cells. J Immunother. 2012, 35:337-43.(IF.4.0)
京公网安备 11010802027423号